CD8(+) T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication

BACKGROUND: Development of AIDS vaccines for effective prevention of circulating HIV-1 is required, but no trial has demonstrated definitive effects on the prevention. Several recent T-cell vaccine trials showed no protection against HIV-1 acquisition although the vaccines induced HIV-1-specific T-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakoshi, Hayato, Zou, Chengcheng, Kuse, Nozomi, Akahoshi, Tomohiro, Chikata, Takayuki, Gatanaga, Hiroyuki, Oka, Shinichi, Hanke, Tomáš, Takiguchi, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029025/
https://www.ncbi.nlm.nih.gov/pubmed/29970102
http://dx.doi.org/10.1186/s12977-018-0429-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029025/
https://www.ncbi.nlm.nih.gov/pubmed/29970102
http://dx.doi.org/10.1186/s12977-018-0429-y

Ejemplares similares